Mixed Bag For Biopharma Funding In 2025: Thoughts From J.P. Morgan, Biotech Showcase

Macro Issues A Challenge, Biotech Fundamentals Positive

 
• By Mandy Jackson
  
Biopharma valuations have leveled off from past declines, but struggle to stay positive (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Conferences